By Matt Jarzemsky Of Dow Jones Newswires NEW YORK (Dow Jones)--Amylin Pharmaceuticals Inc. (AMLN) and Eli Lilly & Co. (LLY) terminated their decade-long diabetes-drug partnership, raising Amylin's stakes on the success of the new treatment Bydureon. ... Amylin, Lilly End Diabetes-Drug Pact
Monday, November 7, 2011
Amylin, Lilly End Diabetes-Drug Pact
By Matt Jarzemsky Of Dow Jones Newswires NEW YORK (Dow Jones)--Amylin Pharmaceuticals Inc. (AMLN) and Eli Lilly & Co. (LLY) terminated their decade-long diabetes-drug partnership, raising Amylin's stakes on the success of the new treatment Bydureon. ... Amylin, Lilly End Diabetes-Drug Pact
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment